Intuitive Surgical, Inc. Stock price
Equities
ISRG
US46120E6023
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
294.98 USD | +0.92% | +0.59% | +11.17% |
Financials (USD)
Sales 2023 * | 7,140 M | Sales 2024 * | 8,163 M | Capitalization | 104 B |
---|---|---|---|---|---|
Net income 2023 * | 1,653 M | Net income 2024 * | 1,927 M | EV / Sales 2023 * | 14,0x |
Net cash position 2023 * | 3,402 M | Net cash position 2024 * | 4,989 M | EV / Sales 2024 * | 12,1x |
P/E ratio 2023 * | 63,7x | P/E ratio 2024 * | 54,4x | Employees | - |
Yield 2023 * | - | Yield 2024 * | - | Free-Float | 99.49% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
1 day | +0.92% | ||
1 week | +0.59% | ||
Current month | +0.92% | ||
1 month | -4.97% | ||
3 months | -13.73% | ||
6 months | +15.47% | ||
Current year | +11.17% |
1 week
288.55
298.35

1 month
283.74
311.38

Current year
222.65
358.07

1 year
180.07
358.07

3 years
180.07
369.69

5 years
120.17
369.69

10 years
38.50
369.69

Managers | Title | Age | Since |
---|---|---|---|
Gary Guthart
CEO | Chief Executive Officer | 57 | 2006 |
Jamie Samath
DFI | Director of Finance/CFO | 51 | 2021 |
Marshall Mohr
PRN | Corporate Officer/Principal | 67 | 2021 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Guthart
BRD | Director/Board Member | 57 | 2008 |
Craig Barratt
CHM | Chairman | 61 | 2020 |
Alan J. Levy
BRD | Director/Board Member | 85 | 2000 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.76% | 30 M$ | +4.38% | - | |
1.86% | 153 M$ | +13.57% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-10-02 | 294.98 | +0.92% | 978,189 |
23-09-29 | 292.29 | -1.30% | 1,294,334 |
23-09-28 | 296.15 | +1.62% | 1,206,565 |
23-09-27 | 291.43 | +0.24% | 1,749,135 |
23-09-26 | 290.74 | -0.86% | 1,297,599 |
Delayed Quote Nasdaq, October 02, 2023 at 04:00 pm EDT
More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows:
- sale of instruments and accessories (56.5%): primarily wrist cuffs;
- sale of robotic systems (27%): systems marketed under the da Vinci brand (1,264 units sold in 2022) and intended primarily for urological, cardio-thoracic, and gynecological surgeries;
- installation and training services (16.5%).
The United States accounts for 66.8% of net sales.
Calendar
2023-10-18
- Q3 2023 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
294.98USD
Average target price
361.91USD
Spread / Average Target
+22.69%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
+11.17% | 104 B $ | |
-8.22% | 93 M $ | |
+4.77% | 94 M $ | |
-83.66% | 77 M $ | |
+14.69% | 225 M $ | |
+112.12% | 61 M $ | |
+23.27% | 239 M $ | |
+438.28% | 213 M $ | |
+24.29% | 117 M $ | |
+36.43% | 237 M $ |